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ABSTRACT 24 
The capacity for intracellular survival within phagocytes is likely a critical 25 
factor facilitating S. aureus dissemination in the host. To date, the majority of 26 
work on S. aureus-phagocyte interactions has focused on neutrophils and to a 27 
lesser extent macrophages, yet we understand little about the role played by 28 
dendritic cells (DCs) in the direct killing of this bacterium. Using bone-marrow-29 
derived DCs (BMDCs) we demonstrate for the first time that DCs can 30 
effectively kill S. aureus, however certain strains of S. aureus have the 31 
capacity to evade DC (and macrophage) killing by manipulation of autophagic 32 
pathways. Strains with high levels of Agr activity were capable of causing 33 
autophagosome accumulation, were not killed by BMDCs and subsequently 34 
escaped from the phagocyte, exerting significant cytotoxic effects. 35 
Conversely, strains that exhibited low levels of Agr activity failed to 36 
accumulate autophagosomes and were killed by BMDCs. Inhibition of the 37 
autophagic pathway by treatment with 3-Methyladenine restored the 38 
bactericidal effects of BMDCs. Using an in vivo model of systemic infection we 39 
demonstrated that the ability of S. aureus strains to evade phagocytic cell 40 
killing and to survive temporarily within phagocytes correlated with 41 
persistence in the periphery and that this effect is critically Agr dependent. 42 
Taken together our data suggests that strains of S. aureus exhibiting high 43 
levels of Agr activity are capable of blocking autophagic flux, leading to the 44 
accumulation of autophagosomes. Within these autophagosomes the bacteria 45 
are protected from phagocytic killing, thus providing an intracellular survival 46 
niche within professional phagocytes, which ultimately facilitates 47 
dissemination. 48 
49 
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INTRODUCTION 50 
Staphylococcus aureus causes a wide range of pathologies from superficial 51 
skin infections to more serious invasive infections associated with significant 52 
morbidity and mortality. In severe cases, localized infections can lead to 53 
bacterial invasion of the vascular system causing life-threatening conditions 54 
such as bacteremia and sepsis. A key factor facilitating this dissemination is 55 
the impressive arsenal of immune evasion strategies available to S. aureus 56 
that enables it to evade recognition and killing by the host immune system (1). 57 
Identifying and disarming the mechanisms by which this organism 58 
circumvents the host’s immune system is an important strategy for identifying 59 
novel therapies.  60 
 61 
Although classically considered an extracellular bacterium, S. aureus is 62 
capable of invading and persisting within a variety of non-professional 63 
phagocytic host cells (2) facilitating tissue persistence and relapsing disease. 64 
Strikingly, this organism is also capable of manipulating professional 65 
phagocytes and there is evidence that S. aureus can survive within 66 
monocytes, macrophages and even neutrophils (3-7). Unlike resident tissue 67 
cells, professional phagocytes are mobile and represent an opportunity for the 68 
bacterium to disseminate from the primary focus of infection to systemic sites. 69 
In a similar mechanism to that employed by traditional intracellular bacteria 70 
such as Mycobacterium tuberculosis and Listeria monocytogenes that utilize 71 
monocytes to disseminate via the bloodstream (8, 9), it has been proposed 72 
that S. aureus may be capable of subverting neutrophils to facilitate its 73 
dissemination (10). S. aureus has also been shown to persist within human 74 
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monocyte-derived macrophages (7) suggesting that these cells may also 75 
provide a potential intracellular niche to facilitate S. aureus dissemination in 76 
vivo. The bulk of the research conducted into the survival within or killing of S. 77 
aureus by phagocytes has focused on neutrophils and, to a lesser extent 78 
macrophages. To date, the contribution of dendritic cells to direct killing of S. 79 
aureus, and the capacity of S. aureus to manipulate these particular 80 
phagocytes has not been explored.  81 
 82 
Despite the fact that the environment inside phagocytes is less than 83 
hospitable, gaining an intracellular niche, even briefly, within these cells 84 
affords a window of opportunity for extended survival and potential 85 
dissemination. Critical to survival is the ability to avoid destruction within 86 
phagolysosomes and S. aureus is equipped with a number of strategies to 87 
resist phagolysosomal killing (11-13). Having circumvented these killing 88 
mechanisms the bacterium can then escape into the cytoplasm, which in most 89 
cases, eventually leads to host cell death, releasing the bacteria into the 90 
extracellular space where it has the opportunity to replicate and infect other 91 
host cells. Phagosomal escape by S. aureus has been shown to depend upon 92 
the regulatory system encoded by the agr locus (7, 14, 15) which controls 93 
expression of a number of virulence factors including the secreted toxin α-94 
haemolysin (Hla), a critical effector molecule essential for S. aureus survival 95 
within macrophages (7). Phenol-soluble modulins (PSMs) are small cytotoxic 96 
alpha-helical peptides. They are categorized into two classes, PSMα and 97 
PSMβ peptides. PSMα peptides are regulated by the Agr system and enable 98 
phagosomal escape by S. aureus from both non-professional (16) and 99 
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professional phagocytes (17, 18). Survival within neutrophils appears to be 100 
dependent upon the accessory regulator SarA, which facilitates the survival of 101 
S. aureus within large vacuoles that are not competent for fusion with 102 
lysosomes (5). While it is clear that phagocytes are critically important for 103 
effective clearance of S. aureus during an infection, it may be that the 104 
intracellular locale of the bacterium post-phagocytosis will dictate whether or 105 
not the phagocytes contribute to host protection or inadvertently play a 106 
deleterious role. 107 
 108 
Autophagy is an important homeostatic process in eukaryotic cells critical for 109 
cell survival. Damaged cytosolic components are removed and recycled in 110 
double-membrane vacuoles called autophagosomes that are characterized by 111 
the recruitment of microtubule-associated protein 1 light chain 3 (LC3) 112 
conjugated to phosphatidylethanolamine (LC3-II) to its membrane (19). These 113 
autophagosomes then fuse with lysosomes and are digested. This process of 114 
autophagosome formation and eventual degradation is termed autophagic flux 115 
(20). Autophagy also plays an important role in host defense against bacteria 116 
that can invade host cells such as Streptococcus pyogenes (21) or facultative 117 
intracellular pathogens such as Mycobacterium tuberculosis (22). These 118 
organisms are sequestered in autophagosomes, which then deliver the 119 
bacteria to the lysosomes for destruction. Some microorganisms (e.g. Coxiella 120 
burnetti and Porphyromonas gingivalis) have evolved mechanisms to subvert 121 
the autophagic machinery of the cell, delaying autophagosomal maturation 122 
and lysosomal fusion thus creating a survival niche within autophagosomes 123 
(23). S. aureus can localize to autophagosomes and inhibit lysosomal fusion 124 
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within HeLa cells while proliferation of S. aureus was impaired within 125 
fibroblasts deficient in the autophagy protein Atg5 (24), indicating an essential 126 
role for the autophagy pathway in facilitating intracellular survival of S. aureus 127 
within non-professional phagocytic cells. In this study, a strain that expresses 128 
low levels of agr failed to colocalise with autophagosomal markers identifying 129 
the requirement for Agr-regulated genes to engage autophagosomes.  130 
 131 
Whether or not S. aureus can manipulate the autophagic process in 132 
professional phagocytes as a means to evade killing remains to be 133 
established. We hypothesized that subversion of autophagy in professional 134 
phagocytes could provide S. aureus with a means to preserve a temporary 135 
intracellular survival niche, in order to facilitate dissemination. We 136 
demonstrate the strain-dependent ability of S. aureus to induce accumulation 137 
of autophagosomes in phagocytes, which appears to correlate with inter-strain 138 
differences in Agr expression. Strains with high levels of Agr activity became 139 
associated with autophagosomes, were not killed by phagocytic cells in vitro 140 
and demonstrated extended intracellular survival within phagocytes in vivo. 141 
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MATERIALS AND METHODS 142 
Bacterial strains 143 
S. aureus strains SH1000 (Clonal complex (CC) 8) and PS80 (CC30) have 144 
been previously described (25, 26). S. aureus clinical isolates were from blood 145 
culture bottles of patients diagnosed with S. aureus bacteremia at St George’s 146 
Healthcare NHS Trust, London. Two isolates were used repeatedly 147 
throughout this study; Sa68 and Sa279. Both of these strains are methicillin 148 
sensitive and belong to the lineage CC1.  149 
 150 
The expression of enhanced green fluorescent protein (GFP) (27) in the PS80 151 
background was achieved through the integration of a non-replicative 152 
integrase vector (pIMC11-GFP) into the phage 11 attachment site. Expression 153 
of eGFP is under the control of the Pxyl/tetO promoter, without repression from 154 
TetR. Chromosomal integration of PS80::pIMC11-GFP was validated with 155 
oligonucleotides IM293/IM294, which amplify across the site of integration 156 
yielding a 0.7kb product in PS80 and a 3.4kb product in PS80::pIMC11-GFP.  157 
 158 
Deletion of the agr locus (agrBDCA genes) within PS80 was achieved by 159 
allelic exchange using pIMAY (28). Primers agr1 and agr2 amplified 532 bp of 160 
DNA upstream of agrB and primers agr3 and agr4 amplified 535 bp of DNA 161 
located downstream of the agrA gene (Table 1). The PCR products were 162 
denatured and allowed to reanneal via the complementary sequences in 163 
primers agr2 and agr3. This was used as template for PCR using primers 164 
agr1 and agr4. The amplimer was cloned into pIMAY (28) between SalI and 165 
EcoRI restriction sites using sequence and ligase independent cloning (29) 166 
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and the resulting plasmid (pIMAY::∆agr) was transformed into DC10B and 167 
verified by DNA sequencing. The plasmid was transformed into 168 
electrocompetent PS80 and deletion of the agr genes was achieved by allelic 169 
exchange as previously described (28). The deletion was confirmed by DNA 170 
sequencing of a PCR amplimer generated using PS80∆agr genomic DNA as 171 
template and the primers agr OUT F and agr OUT R. The mutant did not 172 
produce delta haemolysin on sheep blood agar. 173 
 174 
All bacteria were cultivated from frozen stocks for 24 hours at 37°C on agar 175 
plates. Bacterial suspensions were then prepared in PBS and the 176 
concentrations estimated by measuring the absorbance of the suspension 177 
read at 600nm. CFUs were determined by plating serial dilutions of each 178 
inoculum. 179 
 180 
In the case of PS80-GFP, log phase growth was required for optimal GFP 181 
expression. A single colony was inoculated into TSB overnight and a 182 
subculture to fresh TSB taken the following morning. The concentration of 183 
bacteria in the broth was determined by measuring absorbance at 600nm and 184 
confirmed by streaking on agar plates. 185 
 186 
For immunoflourescent analysis, bacteria were stained with Cell Trace Violet 187 
(CTV, Life Technologies). Stationary phase bacteria in PBS at the appropriate 188 
OD were incubated with CTV for 20min at 37°C under rotation. They were 189 
then washed and resuspended in PBS prior to infection of cells. 190 
 191 
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Animals 192 
Groups of wild type C57BL/6 mice (6-8 weeks) were housed under specific 193 
pathogen free (SPF) conditions in the Trinity College Dublin Comparative 194 
Medicines facility. All animal experiments were conducted in accordance with 195 
the recommendations and guidelines of the Health Products Regulatory 196 
Authority (HPRA), the competent authority in Ireland, and in accordance with 197 
protocols approved by Trinity College Animal Research Ethics Committee. 198 
 199 
Cell Culture  200 
Bone marrow derived dendritic cells (BMDCs) were prepared by culturing 201 
bone marrow cells isolated from C57Bl/6 mice with granulocyte-macrophage 202 
colony stimulating factor (GM-CSF) as described previously (30). On day 10, 203 
loosely adherent cells were collected, washed and reseeded at a 204 
concentration of 2x105 cells/well in media without antibiotic, and rested 205 
overnight.  206 
 207 
Peritoneal macrophages were isolated as previously described (31) and 208 
seeded at 2x105 cells/well in media containing no antibiotics. 209 
 210 
Immortalized Bone Marrow derived Macrophages (iBMM) stably expressing 211 
EGFP-LC3 (GFP-LC3) (32) were cultured in cRPMI (complete Roswell Park 212 
Memorial Institute) media under constant selection with 10μg/ml puromycin. 213 
Cells were seeded at 1 x 106 cells/well on poly-L-lysine coated 19mm 214 
coverslips in 12 well plates. 215 
 216 
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Infection of phagocytes 217 
Cells were infected with live S. aureus at multiplicities of infection (MOI) of 10 218 
or 100 for the indicated times. In some cases, prior to infection cells were 219 
incubated with 10mM 3-Methyladenine (3-MA, Sigma) for 30min. At 2 hours 220 
post infection media was replaced with fresh media containing gentamicin 221 
(200 μg/ml) for 1 hour to kill extracellular bacteria. This media was replaced 222 
with fresh media containing no antibiotics and this was considered time 0.  223 
 224 
For assessment of total killing, cells were infected with live S. aureus at MOI 225 
10 or 100 for the indicated time points and were not gentamicin treated.  226 
 227 
Assessment of bacterial killing  228 
At the indicated time point, infected cells were spun down, the supernatant 229 
removed and cells lysed by the addition of 20 μl 0.1% Triton-X 100. The 230 
supernatant was then re-introduced into the well and mixed with the cell 231 
lysate. Serial dilutions of the suspension were prepared in PBS and plated on 232 
TSA to determine the CFU/ml. Bacterial killing was determined as the % 233 
reduction of CFU in wells containing bacteria and phagocytes as compared to 234 
wells containing bacteria only. 235 
 236 
Assessment of bacterial escape 237 
S. aureus infected BMDCs underwent gentamicin treatment as described 238 
above. At specific time points the cell free supernatants were collected, 239 
serially diluted in PBS and plated on TSA to determine the number of bacteria 240 
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that had escaped into the media, measured as the fold increase in Log 241 
CFU/well from time 0.  242 
 243 
Cell viability assays 244 
To assess S. aureus induced cytotoxicity, BMDCs were infected and treated 245 
with gentamicin as described above. LDH release was measured using the 246 
Pierce LDH Cytotoxicity Assay kit (Thermo Scientific) according to the 247 
manufacturer’s instructions. In some cases cell viability was assessed by the 248 
addition of Propidium Iodine (PI, 1 μg/ml (eBioscience)) and analysis by flow 249 
cytometry. 250 
 251 
Vesicle Lysis Test 252 
Phospholipid vesicles were prepared as described previously (33). Vesicle 253 
lysis test (VLT) was performed using a 1:1 ratio of bacterial supernatant 254 
(cultures grown for 18 h) and pure vesicles and fluorescence intensity 255 
measured at excitation and emission wavelengths of 485-520 nm respectively 256 
on a FLUOstar fluorometer (BMG labtech). Positive and negative controls 257 
were pure vesicles with 0.01% Triton X-100 and HEPES buffer, respectively.  258 
 259 
 Measurement of RNA III expression by qRT-PCR  260 
S. aureus RNA was isolated using the RNeasy Mini Kit (Qiagen) according to 261 
the manufacturer’s instructions with the addition of turbo DNase (Ambion) 262 
following the purification step. RNA was quantified using RNA BR kit (Qubit) 263 
and reverse transcription was performed using the ProtoScript Taq RT-PCR 264 
kit (New England Biolabs) according to manufacturer’s instructions using 265 
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random primers. Standard curves were generated for both gyrase B [gyrFW: 266 
5’-CCAGGTAAATTAGCCGATTGC-3’; gyrRV: 5’AAATCGCCTGCGTTCTAGA 267 
G] and RNAIII primers [rnaIIIFW: 5’- GAAGGAGTGATTTCAATGGCACAAG-268 
3’; rnaIIIRV: 5’ GAAAGTAATTAATTATTCATCTTATTTTTTAGTG AATTTG-3’] 269 
using genomic DNA to determine primer efficiency. Real-time PCR was 270 
performed using the SYBR green PCR master mix (Applied Biosystems) as 271 
previously described (33). 272 
 273 
Western immunoblotting 274 
To detect LC3, BMDCs were infected and treated with gentamicin as 275 
described above. At specified time points BMDCs were lysed in NP-40 lysis 276 
buffer. The protein concentration of the lysates was measured using a 277 
Bradford assay (Thermo Scientific) and equal concentrations of protein were 278 
loaded to each lane of the gel. Samples were separated on a 15% SDS-279 
polyacrylamide gel and transferred to a polyvinylidene difluoride (PVDF) 280 
membrane. The membrane was blocked with 5% (w/v) milk before being 281 
probed with antibody (rabbit anti-LC3 - 1/1000 (Cell Signaling), HRP-282 
conjugated goat anti-rabbit immunoglobulin G (IgG) - 1/10000 (Jackson 283 
Immune)). The membrane was developed with ECL (Mybio) on Bio-Rad 284 
GelDoc.  285 
To detect Hla expression, proteins from filtered bacterial supernatant were 286 
concentrated by trichloracetic acid precipitation, separated on a 12.5% SDS-287 
polyacrylamide gel and transferred to PVDF. The membrane was blocked 288 
in 10% (w/v) milk and probed with polyclonal rabbit anti-Hla IgG (1:1000, (34)) 289 
followed by HRP-conjugated protein A (Sigma). Reactive bands were 290 
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visualized using the LumiGLO reagent and peroxide detection system (Cell 291 
Signaling Technology). 292 
 293 
Confocal imaging 294 
BMDCs were infected, gentamicin treated as described above and 295 
Monodansylcadaverine (MDC, 50μM) added 15 minutes prior to cell fixation. 296 
Cells were then fixed in 2% paraformaldehyde (PFA (Thermo Scientific)). 297 
Alternatively, GFP+LC3-BMMs were infected and treated with gentamicin as 298 
described above. At specific time points post-infection, cells were fixed in 2% 299 
PFA and permeabilised in Triton-X100 (0.1% in PBS). Non-specific binding 300 
was blocked by incubation in 5% BSA before cells were incubated with Alexa 301 
Fluor 555 - conjugated phalloidin (1/100 (Life Technologies)) for 1 hour to 302 
stain actin.  303 
The coverslips were mounted onto glass slides with fluorescent Mounting 304 
medium (DakoCytomation) and analyzed on an Olympus FV1000 laser 305 
scanning confocal microscope. 306 
 307 
In vivo intraperitoneal infection model 308 
Mice were infected with S. aureus (5 x 108 CFU) via intraperitoneal (i.p.) 309 
injection. At specific time points post-infection peritoneal exudate cells (PEC) 310 
were isolated by lavage of the peritoneal cavity with sterile PBS. Lavage fluid 311 
was serially diluted in PBS and plated on TSA to determine the bacterial 312 
burden at the site of infection. Spleens were isolated and homogenized in 2ml 313 
of sterile PBS. Tissue homogenates were then serially diluted in PBS and 314 
plated on TSA to determine the tissue bacterial burden. Blood was collected 315 
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by cardiac puncture with a 27-gauge needle and a heparinized 1ml syringe. 316 
The CFU/ml of blood was determined by serial dilution and plating on TSA 317 
plates.  318 
 319 
To isolate leukocytes, blood was layered onto Histopaque-1083 (Sigma) for 320 
density gradient centrifugation. Leukocytes were collected between the 321 
plasma layer and the pellet containing red blood cells (RBCs) and 322 
extracellular bacteria (35). Isolated leukocytes were then washed well and 323 
resuspended in Fcγ block for flow cytometric analysis or lysed in sterile water 324 
to quantify cell-associated CFU. 325 
 326 
Flow cytometry 327 
PEC or blood leukocytes were blocked in Fcγ block (1μg/ml, eBioscience) 328 
then surface-stained with fluorochrome-conjugated antibodies against Ly6G 329 
(clone 1A8, BDBioscience), F4/80 (clone BM8, eBioscience), CD11c (clone 330 
N418, eBioscience) and CD11b (clone M1/70, eBioscience). Flow cytometric 331 
data were acquired with a BD FACSCanto II (BD Biosciences) and analyzed 332 
using FlowJo software (Tree Star).  333 
 334 
To assess the rate of S. aureus phagocytosis by BMDCs, cells that had been 335 
infected with CTV-labeled S. aureus for 30 minutes or 2 hours, were 336 
incubated with gentamicin (200μg/ml) for 1 hour, washed and fixed in 2% 337 
PFA. They were then analyzed on BD FACSCanto II by gating on Forward-338 
Scatter and Side-Scatter and % CTV+ cells assessed. 339 
 340 
 15
Statistical analysis 341 
Statistical analysis was carried out using GraphPad Prism statistical analysis 342 
software. Differences between groups were analyzed by the unpaired 343 
Students t test or analysis of variance (ANOVA) with appropriate post-test and 344 
using repeated measurers where required. P<0.05 was considered 345 
statistically significant.  346 
347 
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RESULTS 348 
Killing of S. aureus by dendritic cells and macrophages is strain 349 
dependent.  350 
Despite the fact that dendritic cells have been shown to be involved in 351 
coordinating the immune response to S. aureus infection, their contribution to 352 
direct bacterial killing remains to be fully established (36, 37). We compared 353 
the bactericidal capacities of these phagocytic cells to that of macrophages 354 
which have a more clearly defined role in direct killing of S. aureus (38). 355 
Primary BMDCs were infected with two laboratory strains of S. aureus at an 356 
MOI 10 (Figure 1A) and MOI 100 (Figure 1B) and bacterial killing was 357 
monitored over time. Within 6 hours of infection, approximately 70% of 358 
SH1000 was killed and by 16 hours almost 100% of SH1000 had been killed 359 
by the BMDCs at either MOI. In contrast, the BMDCs were unable to kill S. 360 
aureus strain PS80.  361 
 362 
Interestingly, the ability of BMDCs to kill SH1000 appeared to be MOI-363 
dependent. It was reported previously that BMDCs were unable to kill SH1000 364 
at an MOI 0.1 (36). We also failed to detect any killing of SH1000 by BMDCs 365 
at this low MOI but the ability of BMDCs to kill SH1000 by 16 hours became 366 
apparent at as low an MOI as 2 (97.7±1.7% killing).  367 
 368 
To establish if the inability to kill S. aureus strain PS80 was specific to 369 
dendritic cells, we infected primary peritoneal macrophages with both strains 370 
of S. aureus at MOI 100. Similar to that observed with the BMDCs, peritoneal 371 
macrophages efficiently killed SH1000 but were unable to kill PS80 (Figure 372 
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1C). Interestingly, in our hands BMDCs and macrophages demonstrated a 373 
similar capacity to kill S. aureus strain SH1000 (the % killing at 16 hours was 374 
90±6.8% in BMDCs compared to 78.3±6.6% in macrophages). Taken 375 
together these results suggest that BMDCs are capable of killing S. aureus 376 
but that strain-dependent differences may impact upon the ability of both 377 
macrophages and BMDCs to kill the bacterium.  378 
 379 
S. aureus strain PS80 but not SH1000 can escape from dendritic cells 380 
causing associated cytotoxicity.  381 
Given that BMDCs had a different capacity to kill S. aureus strains PS80 and 382 
SH1000, we wanted to confirm that both strains were phagocytosed by 383 
BMDCs at the same rate. BMDCs were infected with CTV-labeled S. aureus 384 
at MOI 100, and the uptake of bacteria into the BMDCs assessed after 30 385 
minutes and 2 hours, following gentamicin treatment to kill any bacteria that 386 
had not been phagocytosed. At 30 min post infection PS80 and SH1000 were 387 
phagocytosed by BMDCs to the same extent, with ~30% of BMDCs staining 388 
positively for CTV-labeled PS80 or SH1000 (Figure 2A). At 2 hours post 389 
infection the % of cells that were CTV-PS80+ increased, alluding to the 390 
survival of this strain inside the cells.  391 
 392 
S. aureus strains SH1000 and PS80 were both phagocytosed by BMDCs to 393 
the same extent but following phagocytosis PS80 was not killed. To establish 394 
whether PS80 escaped from the BMDCs, cells were allowed to phagocytose 395 
the bacteria and any extracellular bacteria were killed by the addition of the 396 
bactericidal antibiotic gentamicin. Cells were washed and incubated in fresh 397 
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medium and the escape of viable bacteria into the supernatant was measured 398 
after 6 and 12 hours incubation. By 6 hours there was evidence of PS80 but 399 
not SH1000 escaping from the BMDCs. By 12 hours the level of PS80 in the 400 
cell culture supernatant significantly higher than SH1000 (Figure 2B). Similar 401 
results were obtained following infection with MOI 10 (data not shown).  402 
 403 
To establish if the escape of S. aureus from BMDCs was associated with 404 
cytotoxicity, LDH release from the infected BMDCs was measured. LDH 405 
activity was similar in uninfected BMDCs and BMDCs infected with SH1000 at 406 
both 6 h and 12 h post-infection, indicating that SH1000 had no effect on the 407 
viability of the infected cells. In contrast, BMDCs infected with PS80 had 408 
significantly higher levels of LDH in the supernatant compared to cells 409 
infected with SH1000 or uninfected BMDCs at both time points (Figure 2C), 410 
indicating significant cytotoxicity.  411 
 412 
Identification of S. aureus bloodstream infection isolates with the ability 413 
to escape phagocytic killing. 414 
S. aureus PS80 and SH1000 are both well-characterized laboratory strains. 415 
However, their relevance to clinical isolates may be limited. Accordingly, 416 
isolates that were recovered from S. aureus bacteremia patients were 417 
collected and screened for cytotoxic effects. BMDCs were infected with each 418 
isolate at MOI 100 and the viability of the infected DCs was assessed after 24 419 
hours by staining with PI. The clinical isolates clustered together into one 420 
group that was cytotoxic to BMDCs in a similar manner to PS80, a second 421 
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group that did not exert any cytotoxic effects, akin to SH1000 and a third, 422 
intermediate group (Figure 3A).  423 
 424 
A representative isolate from both the “PS80-like” group and the “SH1000-425 
like” group were selected for analysis, S. aureus 68 (Sa68) and S. aureus 279 426 
(Sa279). BMDCs were infected with Sa68 or Sa279 at MOI 100. The BMDCs 427 
were capable of killing strain Sa279 but were unable to kill strain Sa68 (Figure 428 
3B). This data suggests that Sa68 is similar to PS80 and may be capable of 429 
escaping from phagocytes. We confirmed that both strains were 430 
phagocytosed by BMDCs at a similar rate by CTV-labeling the bacteria and 431 
infecting BMDCs as described above. Similar to the uptake of PS80 and 432 
SH1000, approximately 30% of BMDCs were associated with CTV+ Sa279 or 433 
Sa68 by 30 min post infection (Figure 3C). We then assessed the ability of 434 
Sa68 to escape from the BMDCs. After 12 hours the level of Sa68 in the cell 435 
culture supernatant was significantly higher than Sa279 (Figure 3D).  436 
 437 
To establish if the ability of Sa68 to escape from the BMDCs correlated with 438 
cytotoxicity, cells were infected with Sa68, Sa279 or left uninfected. Following 439 
gentamicin killing of extracellular non-phagocytosed bacteria, the LDH release 440 
was monitored at 6 h and 12 h. The level of cytotoxicity (LDH release) 441 
associated with Sa68-infected cells was significantly higher than that of 442 
Sa279-infected cells or the uninfected control cells (Figure 3E). 443 
 444 
Infection with PS80, but not SH1000, was associated with increased 445 
accumulation of LC3-II+ autophagosomes. 446 
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S. aureus has previously been shown to associate with autophagosomes in 447 
non-professional phagocytic cells. This provides a niche for the intracellular 448 
survival of S. aureus where it could replicate and eventually escape into the 449 
cytoplasm, ultimately leading to host cell death (24, 39). We postulated that S. 450 
aureus strain PS80 might employ a similar mechanism in BMDCs to evade 451 
killing. To assess autophagy in BMDCs, cells were infected and lysates 452 
prepared at intervals up to 6 hours post-infection and gentamicin killing of 453 
extracellular bacteria. Processing of the autophagic marker LC3 was then 454 
assessed by Western immunoblotting (40). Infection of BMDCs with S. aureus 455 
strain PS80 resulted in the persistence of substantial levels of LC3-II for at 456 
least 6 hours. In comparison, uninfected BMDCs or BMDCs infected with 457 
SH1000 showed no accumulation of LC3+ autophagosomes, although there 458 
was persistently a low level of LC3-II processing which was presumably due 459 
to homeostatic autophagy followed by autosome-lysosome fusion and 460 
degradation of LC3 (Figure 4A).  461 
 462 
To confirm that PS80 was associating with autophagosomes, BMDCs were 463 
infected with CTV-labeled S. aureus strains PS80 or SH1000 and then treated 464 
with gentamicin to kill any extracellular bacteria. Staining with MDC (a 465 
fluorescent compound which accumulates specifically in autophagic vacuoles 466 
(41)) revealed colocalisation between PS80 and the autophagosome. SH1000 467 
was not seen to colocalise to the same extent (Figure 4B). Additionally, RAW 468 
264 macrophages that had been stably transfected with GFP-LC3 (42) were 469 
infected and gentamicin treated as above. Again, CTV-labeled PS80 was 470 
seen to colocalise with GFP-LC3 punctae at 3 hours post infection. In 471 
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comparison, SH1000 did not show the same level of association with GFP-472 
LC3 punctae (Figure 4C).  473 
 474 
To confirm that clinical isolates could also manipulate the autophagic process 475 
BMDCs were infected with Sa68 or Sa279 and lysates prepared after 6 hours. 476 
Processing of LC3 was assessed by Western immunoblotting. Similar to 477 
PS80, Sa68 infected cells had considerable levels of LC3-II present indicating 478 
a delay in the degradation of the autophagosomes. In addition, the level of 479 
LC3-II in Sa279 infected cells was similar to SH1000 infected cells or 480 
uninfected BMDCs, suggesting that these cells had normal autophagic flux 481 
(Figure 5A). 482 
 483 
Engagement of autophagosomes facilitates escape of S. aureus from 484 
phagocytes. 485 
To ascertain if the delay in turnover of autophagosomes was associated with 486 
the ability of S. aureus strains PS80 and Sa68 to escape phagocyte killing, 487 
BMDCs were pre-treated with 3-methyladenine (3-MA), a well-established 488 
PI3K inhibitor that inhibits the induction of autophagy (43), prior to infection 489 
with these two strains. The escape of S. aureus into the supernatant was then 490 
assessed at 6 and 12 hours. In the presence of 3-MA, PS80 and Sa68 escape 491 
into the cell culture supernatant was completely inhibited (Figure 5B). 492 
Associated with this, 3-MA treatment restored the viability of the infected 493 
BMDCs, with the level of LDH activity in the culture supernatant being 494 
significantly reduced following infection with both PS80 and Sa68 (Figure 5C). 495 
Importantly, 3-MA had no direct effect on bacterial viability after 18 hours 496 
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incubation (7.90±0.13 vs. 7.55±0.39 Log CFU/ml, for S. aureus alone vs. S. 497 
aureus + 3-MA).  498 
 499 
Differential expression of Agr by S. aureus strains correlates with their 500 
ability to engage autophagosomes.   501 
It has previously been shown that the ability of S. aureus to divert from the 502 
endosomal pathway to autophagosomes is driven by factors that are under 503 
the control of the Agr regulatory system (24). We hypothesized that the 504 
different abilities of strains to delay autophagic flux may be associated with 505 
the level of expression of Agr. Consequently, Agr activity was measured using 506 
a vesicle lysis test (VLT). This assay measures the interaction of PSM toxins 507 
with lipid vesicles (33). The PSMα peptide δ-toxin is translated from a short 508 
open reading frame located within the regulatory RNAIII molecule while 509 
transcription of the other psm genes is activated directly by the AgrA response 510 
regulator of the Agr two component signal transduction system that responds 511 
to high cell density. Expression of these membrane-damaging toxins is a 512 
direct manifestation of the level of expression of Agr in the stationary phase of 513 
growth (44). S. aureus strains PS80 and Sa68 induced significantly more 514 
vesicle lysis than SH1000 and Sa279 (Figure 6A) suggesting a greater level 515 
of Agr activity in these strains. To further assess the expression of Agr, RNAIII 516 
was measured. Consistent with the VLT, RNAIII was expressed at higher 517 
levels by S. aureus strains PS80 and Sa68 as compared to SH1000 and 518 
Sa279 (Figure 6B). Taken together we can conclude that the S. aureus strains 519 
PS80 and Sa68 that induce autophagosome accumulation, exhibit a greater 520 
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level of Agr activity than SH1000 and Sa279 which have no effect on 521 
autophagosomes.  522 
 523 
Deletion of the agr locus prevents LC3-II accumulation and facilitates 524 
bacterial killing. 525 
In order to investigate if strain dependent differences in bacterial killing and 526 
the delay of normal autophagic flux were under the control of Agr regulated 527 
genes we generated an agr mutant strain of PS80 by allelic exchange. 528 
BMDCs were infected with PS80 and PS80Δagr and bacterial killing was 529 
monitored over time. By 6 h post infection almost 100% of PS80Δagr were 530 
killed (Figure 7A) as compared to the parental strain, which failed to be killed. 531 
Furthermore, the escape of PS80 from the BMDCs was significantly inhibited 532 
in the absence of agr (1.29±0.28 fold increase in Log CFU/well from T0 PS80 533 
versus 0.52±0.12 fold reduction in Log CFU/well compared to T0 PS80Δagr) 534 
12 hours post infection. 535 
 536 
In addition, the accumulation of LC3-II in infected BMDCs was also measured 537 
after 6 h of infection with PS80 or PS80Δagr. LC3-II expression was reduced 538 
in cells infected with PS80Δagr compared to the wild type, further proving that 539 
the agr locus plays a role in PS80’s ability to block autophagic flux. However, 540 
the LC3-II processing was not reduced to baseline levels (Figure 7B), 541 
suggesting that PS80 may be expressing alternative, non-Agr regulated 542 
genes, which have some capacity to delay autophagic flux.      543 
 544 
 Agr influences S. aureus persistence in vivo. 545 
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Having established that both laboratory and clinical strains of S. aureus can 546 
subvert autophagy to evade phagocytic killing, it was important to determine 547 
whether this phenomenon affected infection outcome in vivo. Groups of wild-548 
type mice were infected with S. aureus strains PS80, SH1000, Sa68, Sa279 549 
or PS80Δagr by i.p. injection. At 3 hours post challenge blood was collected 550 
and total bacterial burden in the blood was quantified (Table 2). As expected, 551 
there were significant differences in the bacterial burdens in the blood 552 
following infection with different strains. It has previously been documented 553 
that strains of S. aureus expressing Capsular Polysaccharide (CP) seed the 554 
blood stream from the peritoneal cavity in greater numbers than acapsular 555 
strains (45, 46). PS80 is known to express CP 8 (25), SH1000 and PS80Δagr 556 
are a-capsular (26, 47) and the CP-expression of the clinical strains are 557 
unknown. In order to prove that the differential abilities of these strains to 558 
seed the blood were not simply due to differences in CP expression levels, 559 
mice were infected with PS80 or an isogenic mutant of PS80, RMS-1 that is a-560 
capsular (46). 3 hours post infection blood was isolated and total bacterial 561 
burden quantified. There was no significant difference in the levels of bacteria 562 
recoverable from the blood between the two groups (PS80 v RMS-1; 4±0.2 v 563 
3.7±0.1 Log CFU/ml), confirming that the observed differences in bacteremia 564 
levels were not as a result of differential CP expression. 565 
 566 
To prove that differences in bacterial burden in the blood were due to the 567 
differential abilities of individual strains to survive intracellularly, mice were 568 
infected with S. aureus strains PS80, SH1000, PS80Δagr, Sa68 or Sa279. At 569 
3 hours post infection the total leukocytes were separated from the RBC and 570 
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extracellular bacteria by centrifugation through Histopaque 1083. Leukocytes 571 
were then washed thoroughly and lysed to quantify viable intracellular S. 572 
aureus. The number of intracellular bacteria recovered was significantly 573 
higher in PS80 infected animals compared to PS80Δagr (Figure 8A) or 574 
SH1000 (Figure 8B) infected animals. The same trend was seen in the clinical 575 
strains, with significantly higher levels of Sa68 recovered from the blood 576 
leukocytes in comparison to Sa279 (Figure 8C). This suggests that PS80 and 577 
Sa68 are capable of surviving within phagocytes in vivo, potentially facilitating 578 
systemic dissemination and persistence. Consistent with this, animals infected 579 
with PS80 demonstrated a significantly increased bacterial burden in the 580 
spleen at 12 hours post challenge as compared to the animals infected with 581 
the PS80Δagr (Figure 8D) or SH1000 (Figure 8E). Unfortunately, due to 582 
limitations in cell numbers we were unable to analyze autophagic flux in 583 
individual blood leukocyte populations ex vivo. 584 
 585 
Finally, to establish which specific leukocyte populations in the blood were 586 
harboring intracellular S. aureus, GFP-expressing PS80 was injected into the 587 
peritoneum. At 3 hours post infection total leukocytes were isolated from the 588 
blood. These leukocytes were stained with a panel of antibodies against 589 
various surface markers in order to identify the phagocyte populations 590 
containing intracellular bacteria. As expected, the predominant cell type 591 
associated with GFP-expressing PS80 was found to be PMN. Surprisingly, 592 
DCs accounted for the cell type that contained the second largest population 593 
of PS80-GFP+ cells. In contrast, only a low number of monocytes were 594 
associated with PS80-GFP+ (Figure 8F). This supports the contention of this 595 
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study that DCs play an important direct role in phagocytosis and clearance of 596 
S. aureus.   597 
598 
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Discussion 599 
Undoubtedly, the success of S. aureus as a pathogen can be attributed to its 600 
inherent ability to disarm the host’s protective immune responses. In 601 
particular, S. aureus possesses a unique arsenal of virulence factors that can 602 
circumvent the bactericidal effects of phagocytes and can manipulate these 603 
cells, even parasitizing them to facilitate an intracellular lifestyle. Here we 604 
provide significant new insights into the molecular mechanisms involved. 605 
Analysis of several S. aureus strains revealed that, despite being 606 
phagocytosed to similar extents, some strains could elude phagocytic killing, 607 
subsequently lysing phagocytes and escaping. The ability to evade killing was 608 
directly associated with the capacity of these strains to inhibit normal 609 
autophagic flux within the cells. We showed that the ability of S. aureus to 610 
subvert autophagic pathways and survive within phagocytes is associated 611 
with Agr activity as strains with lower levels of Agr exhibited normal, 612 
homeostatic turnover of autophagosomes. Moreover, we established that the 613 
level of Agr expression is directly linked with the ability of S. aureus to survive 614 
intracellularly within phagocytes in vivo, suggesting that this phenomenon is 615 
related to the ability of S. aureus to subvert autophagy. 616 
 617 
Previous studies have documented a protective role for dendritic cells during 618 
S. aureus infection. Depletion of dendritic cells was associated with increased 619 
mortality during S. aureus blood stream infection (36), and impaired bacterial 620 
clearance in a S. aureus pneumonia model (37). In both cases the beneficial 621 
effects afforded by dendritic cells were dependent upon their ability to control 622 
the inflammatory response. In this study, we demonstrated for the first time 623 
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that dendritic cells also have the potential to contribute to host protection by 624 
directly killing S. aureus. The bactericidal effects of dendritic cells were found 625 
to be comparable to those of macrophages, with both cell types being 626 
effective in reducing growth of S. aureus strain SH1000. Consequently 627 
we chose to use DCs as a representative phagocyte to investigate the 628 
mechanisms by which S. aureus can parasitize these cells. Of note, our 629 
finding contrasted with a previously published study, which concluded that 630 
BMDCs do not play a major role in direct killing of S. aureus (36). In that 631 
study, dendritic cells were infected with S. aureus at a very low ratio (MOI 632 
0.1). Given that the uptake of bacteria by macrophages has been directly 633 
linked to MOI (48), we hypothesized that bacteria must reach a critical 634 
threshold to ensure appropriate activation of the phagocyte before phagocytic 635 
killing can occur. To test this, dendritic cell killing assays were repeated using 636 
SH1000 at an MOI 0.1 and no killing was observed. However the ability of 637 
BMDCs to kill SH1000 by 16 hours became apparent at as low an MOI as 2 638 
(97.7±1.7% killing). 639 
 640 
 Our previous work demonstrated that S. aureus strains SH1000 and PS80 641 
possess distinct capacities to activate innate signaling pathways in dendritic 642 
cells resulting in different levels of IL-1β production (49). Accordingly, we 643 
wanted to dissect the interaction of these particular strains with dendritic cells. 644 
Interestingly, while both primary BMDCs and peritoneal macrophages were 645 
able to kill S. aureus strain SH1000 they lacked the ability to kill PS80. PS80 646 
avoided the bactericidal effects of phagocytes and instead escaped from the 647 
cells by inducing cell death. In contrast, once phagocytosed, SH1000 did not 648 
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escape from the phagocyte, and cells that ingested this strain remained viable 649 
for up to 24 hours post infection. Importantly both strains of S. aureus were 650 
efficiently phagocytosed by the dendritic cells, implying that manipulation of 651 
the phagocyte response by PS80 was exerted once it became intracellular.  652 
 653 
S. aureus strain PS80 has previously been shown to survive intracellularly 654 
within neutrophils isolated from S. aureus surgical site infections (50). We 655 
have now demonstrated that PS80 establishes its intracellular survival niche 656 
within phagocytes through subversion of the autophagic pathway. Following 657 
infection of BMDCs, PS80 prevented the constitutive degradation of 658 
autophagosomes by lysosomes, leading to the accumulation of LC3-II. In 659 
contrast, S. aureus strain SH1000 did not interfere with the homeostatic 660 
turnover of the autophagic machinery. Furthermore, BMDCs that had been 661 
treated with MDC (which accumulates in the autophagosome) post-infection, 662 
showed colocalisation between the autophagosome and PS80 but not 663 
SH1000. In addition, macrophages that were stably transfected with GFP-LC3 664 
also demonstrated colocalisation of PS80 with LC3-II punctae, indicating the 665 
interaction of the bacterium with autophagosomes. Upon invasion of non-666 
professional phagocytes S. aureus has been shown to subvert autophagy 667 
enabling replication within the autophagosome, and subsequent lysis of the 668 
host cell (24). Consistent with this we have demonstrated that the cytotoxic 669 
effects exerted by S. aureus strain PS80 on BMDCs are associated with the 670 
subversion of autophagy. Treatment of BMDCs with the autophagy inhibitor 3-671 
MA protected cells from PS80-induced cytotoxicity and simultaneously 672 
prevented escape of the bacterium from the phagocyte.  673 
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Importantly, bloodstream infection isolates with comparable phenotypes to 674 
PS80 and SH1000 were identified, highlighting the clinical relevance of this 675 
phagocyte evasion strategy for facilitating systemic infection. Similar to PS80, 676 
Sa68 was not killed by BMDCs and could escape from the cells causing 677 
associated cytotoxicity. In contrast, Sa279 behaved more like SH1000 and 678 
was killed by the BMDCs. This was consistent with the observation that Sa68 679 
induced significant LC3-II accumulation in BMDCs, while inhibition of 680 
autophagy using 3-MA reduced escape of Sa68 from BMDCs. 681 
 682 
The ability of S. aureus to subvert autophagy in non-phagocytic cells is 683 
controlled by the Agr system and has been shown to specifically depend upon 684 
Agr regulated expression of α-toxin (Hla) (24, 39). In vitro, agr and hla 685 
mutants of S. aureus fail to trigger autophagy, are delivered efficiently to the 686 
lysosome where they are degraded and thus cannot survive intracellularly for 687 
extended periods. However, a recently published in vivo study has shown that 688 
while autophagy plays an important role in conferring protection against S. 689 
aureus lethality by mediating tolerance towards the cytotoxic effects of Hla, 690 
infection with a Hla mutant strain actually caused increased bacterial burden 691 
in wild-type mice in comparison to Atg16L1HM mice (that display reduced 692 
autophagy). This indicates that Hla may actually be dispensable in the 693 
exploitation of autophagy in the context of intracellular bacterial survival (51). 694 
Interestingly, when we profiled Hla expression among our strains, it did not 695 
correlate with the abilities of these stains to inhibit autophagic flux in 696 
phagocytes. S. aureus strains PS80 and Sa68 were comparable in their 697 
abilities to manipulate autophagy in order to evade phagocytic killing however 698 
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PS80 was a high Hla producer whereas Sa68 was Hla negative. Furthermore, 699 
SH1000 and Sa279 are both killed by DCs and fail to accumulate 700 
autophagosomes but SH1000 does express low levels of Hla and there is no 701 
expression detectable in Sa279 (Supplemental Fig 1). S. aureus strains PS80 702 
and Sa68 that evade phagocytic killing through the subversion of autophagy 703 
did express higher levels of Agr RNAIII and membrane-damaging cytolytic 704 
peptide toxins  compared to SH1000 and Sa279 which did not have any 705 
appreciable effect on autophagy and were killed by the phagocytes. Crucially, 706 
we have also shown that Agr activity dictated the ability of S. aureus to 707 
survive within phagocytes in vivo. Using an agr mutant of PS80, we 708 
demonstrated a reduced ability of PS80Δagr to survive within leukocytes 709 
isolated from the peripheral blood following systemic challenge compared to 710 
wild-type PS80. In addition SH1000 (which exhibited reduced Agr activity) 711 
also had a significantly reduced capacity to survive within peripheral blood 712 
leukocytes in vivo confirming that the inability of PS80Δagr to survive in the 713 
phagocytes is not an artifact of the mutation to agr. Similarly, the clinical strain 714 
Sa279 (which also exhibits reduced Agr activity) shows significantly reduced 715 
survival in the circulating leukocytes in comparison to Sa68. It appears that 716 
the Agr-dependent predilection of PS80 and Sa68 for associating with 717 
autophagosomes enables them to survive within circulating leukocytes thus 718 
potentially increasing their capacity for systemic dissemination. Consistent 719 
with this, bacterial burdens in the spleen were significantly elevated in PS80 720 
infected mice as compared to animals infected with PS80Δagr or SH1000 721 
suggesting that intracellular survival in the autophagosome facilitates 722 
increased persistence in the periphery of the host. 723 
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Until this study Hla was the only known S. aureus virulence factor implicated 724 
in the induction of autophagy (39). However, the pattern of Hla expression 725 
between the strains used in this study was not sufficient to explain the 726 
phenotypes observed and it raises the question whether other Agr-regulated 727 
factors might also be capable of manipulating autophagy. Intriguingly, the VLT 728 
used to assess Agr activity measures PSM activity in culture supernatants of 729 
S. aureus and the pattern of vesicle lysis corresponds exactly with the 730 
observed phenotypes (33). Thus it is tempting to speculate that these toxins 731 
may also have an as yet undocumented role in the induction of autophagy in 732 
phagocytic cells. Interestingly, melittin, a component of bee sting venom that 733 
is an α-helical, amphipathic antimicrobial peptide, similar to δ-toxin (52) has 734 
previously been shown to induce autophagic cell death in trypanosomes (53). 735 
In addition αPSMs trigger phagosomal escape by S. aureus in the monocytic 736 
cell line THP-1s (17), allowing the bacteria to replicate in the cytoplasm, 737 
leading to cell lysis (18). Autophagy has been shown to respond to both 738 
bacteria in the cytosol and within damaged phagosomes (54) supporting the 739 
notion that certain strains of S. aureus deliberately induce autophagy by 740 
causing damage to the phagosome. Then, by inhibiting the digestion of the 741 
autophagosomes by the lysosomes they survive within the autophagosome. A 742 
comprehensive analysis of the role played by PSMs in the induction of and 743 
engagement with autophagic pathways is warranted but is beyond the scope 744 
of this current study. 745 
 746 
The precise mechanism by which S. aureus subverts autophagosomes has 747 
yet to be defined. It has previously been shown that autophagosomes may 748 
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form around a phagosome that has been damaged by internalized bacteria 749 
such as Salmonella enterica (55), suggesting that both strains of S. aureus 750 
may be phagocytosed normally but that PS80 may then damage the 751 
phagosome deliberately in order to secrete itself within an autophagosome. 752 
Alternatively, Gresham et al. have suggested that S. aureus can be taken up 753 
unconventionally by neutrophils via macropinocytosis into “large spacious 754 
vacuoles” (5). Other studies have shown that autophagy proteins can be 755 
recruited to single-membrane vacuoles such as macropinosomes (56). This 756 
may suggest an alternative internalization route for certain strains of S. 757 
aureus. While some strains are phagocytosed and killed by phagolysosomal 758 
fusion others may become internalized via macropinocytosis, which facilitates 759 
subversion of autophagic pathways in order to promote their survival.  760 
 761 
Interestingly, PS80 can survive within several different phagocytic cell types in 762 
vivo. Consistent with previous studies (5, 50) we showed that neutrophils are 763 
the main intracellular reservoir for S. aureus. However DCs showed higher 764 
levels of viable intracellular bacteria than monocytes, further supporting our 765 
belief that these cells are critical in regulating the outcome of S. aureus 766 
infection. The primary role of DCs is to migrate to the lymph node following 767 
antigen uptake in order to activate the adaptive immune response. Therefore 768 
the ability to survive within these cells may be an attractive route of 769 
dissemination for S. aureus.  770 
 771 
This study contributes to the growing literature that links subversion of 772 
autophagosomes by S. aureus with intracellular survival (24, 39). Our data 773 
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demonstrates that S. aureus strain PS80 and a comparable clinical isolate that 774 
express high levels of Agr prevent constitutive degradation of LC3-II+ 775 
autophagosomes in order to survive and escape killing by professional 776 
phagocytes. Strains that had a lower level of Agr expression did not affect the 777 
degradation of autophagosomes in BMDCs and were efficiently killed. This 778 
study implicates autophagy as a mechanism to facilitate temporary intracellular 779 
survival of certain S. aureus strains within different phagocytes, maximizing 780 
their potential for dissemination and persistence in vivo.   781 
 782 
The notion that S. aureus could parasitize neutrophils to facilitate 783 
dissemination has already been proposed (57) and our studies support the 784 
hypothesis that other phagocytes may also act as “Trojan horses” for the 785 
metastasis of S. aureus provided that the infecting organism possesses the 786 
appropriate tools to subvert autophagosomes. Given that our findings were 787 
replicated in clinically relevant strains, it is tempting to speculate that 788 
identifying S. aureus isolates which can inhibit autophagic flux by measuring 789 
Agr activity may predict invasive disease potential.  790 
791 
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 1001 
Table 1:  Primers used in deletion of agr from PS80. 1002 
 1003 
IM293 TATACCTCGATGATGTGCATAC 
IM294 GCTGATCTAACAATCCAATCCA 
agr1 
CCTCACTAAAGGGAACAAAAGCTGGGTACCACTCTACTAG
CAAATGTTACTC 
agr2 CAAACTGGTCAATTTTGTTATC 
agr3 
CACATCGGTTGCTAAAATCCTTAATAAGATAATAAAGTCAG
TTAAC 
agr4 
CGACTCACTATAGGGCGAATTGGAGCTCAGGATTTTAGCA
ACCGATGTG 
agr OUT F AATACATAGCACTGAGTCCAAG 
agr OUT R GGGATGCCTTTATTGGTGCAG 
 1004 
 1005 
 1006 
 1007 
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Table 2: Bacterial burden in the blood 1008 
 1009 
Figure Legends 1010 
Figure 1: Killing of S. aureus by dendritic cells and macrophages is 1011 
strain dependent.  1012 
BMDCs were infected with PS80 or SH1000 at an MOI of 10 (A) or 100 (B). 1013 
Alternatively, peritoneal macrophages were infected with either strain at MOI 1014 
100 (C). % killing of bacteria was determined by comparing the total CFU in 1015 
the presence of phagocytes to bacteria in media only. Results expressed as 1016 
mean ± SEM at each time point, n=3/4. *p<0.05, ***p<0.001 compared to 1017 
other strain by repeated measures two-way ANOVA with Bonferroni post-test. 1018 
 1019 
Figure 2: S. aureus strain PS80 but not SH1000 can escape from 1020 
dendritic cells causing associated cytotoxicity.  1021 
BMDCs were infected with either CTV-labeled PS80 or SH1000 at MOI 100. 1022 
% uptake of bacteria was measured at 30 min or 2 hours (A). Following 1023 
infection of BMDCs with PS80 or SH1000 at MOI 100, escape of each strain 1024 
 PS80 SH1000 Sa68 Sa279 PS80Δagr 
Log CFU/ml 
(Mean±SEM) 
3.63±0.12 
 
2.93±0.26 
 
3.92±0.39 
 
2.37±0.49 
 
2.28±0.29 
 
Significance 
compared to 
PS80 
 
n.s. 
 
p<0.01 
** 
 
n.s. 
 
p<0.001 
*** 
 
p<0.0001 
*** 
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into the cell culture media was assessed at 6 hours and 12 hours (B). LDH 1025 
levels were assessed in the supernatant of both infected and uninfected 1026 
BMDCs (C). Results expressed as mean±SEM (A&B) or mean±SD (C). n=3/4 1027 
(A&B), representative of 3 independent experiments (C), *p<0.05, ***p<0.001 1028 
by repeated measures one or two-way ANOVA with appropriate post-test. 1029 
 1030 
Figure 3: Identification of clinical bloodstream isolates with the ability to 1031 
escape phagocytic killing. 1032 
BMDC viability was screened by PI staining 24 hours post infection with a 1033 
panel of clinical strains, identifying “PS80-like” strains (black), “SH1000-like” 1034 
strains (white) and “intermediate” strains (checked) (A). BMDCs were infected 1035 
with Sa68 or Sa279 and % killing of bacteria was determined by comparing 1036 
total CFU in the presence of phagocytes to bacteria in media only (B). BMDCs 1037 
were infected with either CTV-labeled Sa68 or Sa279 at MOI 100 and % 1038 
uptake of each strain was determined by flow cytometry at 30 min or 2 hours 1039 
post infection (C). Following infection of BMDCs with Sa68 or Sa279 at MOI 1040 
100, escape of each strain into the cell culture media was assessed at 6 1041 
hours and 12 hours (D). LDH levels were assessed in the supernatant of both 1042 
infected and uninfected BMDCs (E). Results expressed as mean±SEM (A-D) 1043 
or mean±SD (E). n=2/6 (A-D), representative of 3 independent experiments 1044 
(E), *p<0.05, ***p<0.001 by repeated measures one or two-way ANOVA with 1045 
appropriate post-test. 1046 
 1047 
 47
Figure 4: S. aureus strain PS80 inhibits normal autophagic flux in 1048 
phagocytes. 1049 
BMDCs were infected with S. aureus strains PS80 or SH1000. At indicated 1050 
time points cells were lysed and expression of LC3 analysed by Western 1051 
immunoblotting. Bands show conversion of LC3-I to LC3-II. β-actin was 1052 
measured as a loading control. Representative blots from n=3 independent 1053 
experiments are shown (A). At 6 hours post infection with CTV-labeled 1054 
bacteria, BMDCs were stained with MDC and fixed to be viewed under a 1055 
fluorescent microscope. Blue, bacteria; yellow, MDC; white arrows indicate 1056 
colocalisation of bacteria and LC3-II (B). At 3 hours post infection with CTV-1057 
labeled bacteria, GFP-LC3 iBMM were fixed, permeabalised and stained for 1058 
phalloidin to be viewed under a fluorescent microscope. Blue, bacteria; green,  1059 
LC3;  red,  phalloidin; white arrows indicate colocalisation of bacteria and 1060 
LC3-II (C). See also enlarged images showing the extent of co-localization. 1061 
 1062 
Figure 5: Inhibition of autophagic flux facilitates escape of S. aureus 1063 
from phagocytes. 1064 
BMDCs were infected with S. aureus strains PS80, SH1000, Sa68 and 1065 
Sa279. At 6 hours cells were lysed and expression of LC3 analysed by 1066 
Western immunolotting. Bands show conversion of LC3-I to LC3-II. β-actin 1067 
was measured as a loading control. A representative blot is shown (A). 1068 
BMDCs were pretreated with 3-MA for 30min and infected with either PS80 or 1069 
Sa68 (MOI 100). Escape of each strain into the cell culture media was 1070 
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assessed at 6 hours and 12 hours (B). LDH levels were assessed in the 1071 
supernatant of 3-MA pretreated and untreated BMDCs that were infected with 1072 
either PS80 or Sa68 (C). Results expressed as mean±SEM (A&B) or 1073 
mean±SD (C), n=4/6 (A&B), representative of 3 independent experiments (C). 1074 
***p<0.001 by repeated measures two-way ANOVA with Bonferroni post-test. 1075 
 1076 
Figure 6. S. aureus strains exhibit distinct levels of Agr activity as 1077 
assessed by VLT and  RNA III gene expression. 1078 
Bacterial supernatant was incubated at 1:1 ratio with lipid vesicles and 1079 
fluorescence intensity recorded as a measure of vesicle lysis (A). RNAIII 1080 
activity was measured using quantitative RT-PCR, as a ratio of RNA III and 1081 
gyrB transcript number (B). Results expressed as mean±SEM. n=3/4, 1082 
*p<0.05, **p<0.01 ***p<0.001 by one-way ANOVA with Tukey post-test. 1083 
 1084 
Figure 7: PS80Δagr is killed by BMDCs and leads to reduced 1085 
accumulation of LC3-II. 1086 
BMDCs were infected with S. aureus strains PS80 or PS80Δagr at MOI 100. 1087 
% killing of bacteria was determined by comparing total CFU in the presence 1088 
of BMDCs to bacteria in media only (A). At 6 hours cells were lysed and 1089 
expression of LC3 analysed by Western immunoblotting. β-actin was 1090 
measured as a loading control. (B). Results expressed as mean ± SEM. n=3 1091 
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(A), representative of 3 individual experiments (B), *p<0.05, **p<0.01, 1092 
***p<0.001 by repeated measures two-way ANOVA with Bonferroni post-test. 1093 
 1094 
Figure 8: Intracellular persistence of S. facilitates infection in vivo. 1095 
Groups of mice were challenged with S. aureus strains PS80 (A,B,D,E), 1096 
PS80Δagr (A&D), SH1000 (B&E), Sa68, Sa279 (C) or GFP-PS80 (F) (5 x 108 1097 
CFU) via the intraperitoneal route.  At 3 hours post challenge blood was 1098 
collected, total leukocytes isolated, washed and lysed. Cell-associated 1099 
bacteria were expressed per 105 cells (A-C). At 12 hours post challenge, 1100 
spleens were isolated, homogenized and the bacterial burden assessed 1101 
(D&E). Leukocytes isolated 3 hours post challenge were also analysed by 1102 
flow cytometry and CD11b+F480-Ly6G+ (neutrophil (PMN)), CD11c+ 1103 
(dendritic cells (DC)) and CD11b+F480+Ly6G- (monocyte (MΦ)) populations 1104 
that were GFP+ determined (F). Results expressed as mean±SEM, line 1105 
indicates mean, n=5/12, *p<0.05, **p<0.01 by unpaired students t-test or one-1106 
way ANOVA with Tukey post-test.  1107 








